Trials / Terminated
TerminatedNCT01142323
Pilot Study of Fenofibrate for PSC
Pilot Study of Fenofibrate in Primary Sclerosing Cholangitis
- Status
- Terminated
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- University of Miami · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether fenofibrate is safe and effective in the treatment primary sclerosing cholangitis (PSC).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | fenofibrate | 160 mg po daily |
Timeline
- Start date
- 2010-10-01
- Primary completion
- 2012-12-01
- Completion
- 2012-12-01
- First posted
- 2010-06-11
- Last updated
- 2018-02-06
- Results posted
- 2013-04-23
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01142323. Inclusion in this directory is not an endorsement.